These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36312366)

  • 1. Proteomic Analysis Reveals Distinct Protein Corona Compositions of Citrate- and Riboflavin-Coated SPIONs.
    Mekseriwattana W; Thiangtrongjit T; Reamtong O; Wongtrakoongate P; Katewongsa KP
    ACS Omega; 2022 Oct; 7(42):37589-37599. PubMed ID: 36312366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells.
    Mekseriwattana W; Guardia P; Herrero BT; de la Fuente JM; Kuhakarn C; Roig A; Katewongsa KP
    Nanoscale Adv; 2022 Apr; 4(8):1988-1998. PubMed ID: 36133415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages.
    Vogt C; Pernemalm M; Kohonen P; Laurent S; Hultenby K; Vahter M; Lehtiö J; Toprak MS; Fadeel B
    PLoS One; 2015; 10(10):e0129008. PubMed ID: 26444829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings.
    Sakulkhu U; Mahmoudi M; Maurizi L; Salaklang J; Hofmann H
    Sci Rep; 2014 May; 4():5020. PubMed ID: 24846348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats.
    Sakulkhu U; Maurizi L; Mahmoudi M; Motazacker M; Vries M; Gramoun A; Ollivier Beuzelin MG; Vallée JP; Rezaee F; Hofmann H
    Nanoscale; 2014 Oct; 6(19):11439-50. PubMed ID: 25154771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effects of Bovine Serum Albumin on Superparamagnetic Iron Oxide Nanoparticles Evaluated in the Nematode
    Gonzalez-Moragas L; Yu SM; Carenza E; Laromaine A; Roig A
    ACS Biomater Sci Eng; 2015 Nov; 1(11):1129-1138. PubMed ID: 33429554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and Dual Surfactants Coated Hydrophilic Superparamagnetic Iron Oxide Nanoparticles for Magnetic Fluid Hyperthermia Applications.
    Sudame A; Kandasamy G; Maity D
    J Nanosci Nanotechnol; 2019 Jul; 19(7):3991-3999. PubMed ID: 30764960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.
    Hong SC; Lee JH; Lee J; Kim HY; Park JY; Cho J; Lee J; Han DW
    Int J Nanomedicine; 2011; 6():3219-31. PubMed ID: 22238510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
    Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
    Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-identity and fate of albumin-coated SPIONs evaluated in cells and by the C. elegans model.
    Yu SM; Gonzalez-Moragas L; Milla M; Kolovou A; Santarella-Mellwig R; Schwab Y; Laromaine A; Roig A
    Acta Biomater; 2016 Oct; 43():348-357. PubMed ID: 27427227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
    Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpolymeric surface-coated iron oxide nanoparticles for in vivo molecular imaging: biodegradation, biocompatibility, and multiplatform.
    Lee CM; Cheong SJ; Kim EM; Lim ST; Jeong YY; Sohn MH; Jeong HJ
    J Nucl Med; 2013 Nov; 54(11):1974-80. PubMed ID: 24050935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
    Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
    Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications.
    Wei H; Hu Y; Wang J; Gao X; Qian X; Tang M
    Int J Nanomedicine; 2021; 16():6097-6113. PubMed ID: 34511908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona.
    Ashby J; Pan S; Zhong W
    ACS Appl Mater Interfaces; 2014 Sep; 6(17):15412-9. PubMed ID: 25144382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility.
    Liu T; Bai R; Zhou H; Wang R; Liu J; Zhao Y; Chen C
    RSC Adv; 2020 Feb; 10(13):7559-7569. PubMed ID: 35492144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.